Aurora Cannabis Inc. (ACB.TO)
CAD 6.11
(-4.83%)
CAD 6.11
(-4.83%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.60 CAD | 80.42% |
| 2022 | -8.17 CAD | -2.25% |
| 2021 | -7.99 CAD | 80.52% |
| 2020 | -41.01 CAD | 88.01% |
| 2019 | -342.14 CAD | 21.45% |
| 2018 | -435.59 CAD | -23269.68% |
| 2017 | 1.88 CAD | 435.71% |
| 2016 | -0.56 CAD | -5.66% |
| 2015 | -0.53 CAD | 64.19% |
| 2014 | -1.48 CAD | -393.33% |
| 2013 | -0.30 CAD | -3.45% |
| 2012 | -0.29 CAD | -20.83% |
| 2011 | -0.24 CAD | 0.0% |
| 2010 | -0.24 CAD | -574.16% |
| 2009 | -0.04 CAD | 70.33% |
| 2008 | -0.12 CAD | 36.84% |
| 2007 | -0.19 CAD | -2535.9% |
| 2006 | 0.01 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q3 | -0.32 CAD | 38.46% |
| 2023 Q1 | -0.06 CAD | 93.08% |
| 2023 FY | - CAD | 80.42% |
| 2023 Q2 | -0.52 CAD | -838.63% |
| 2022 FY | - CAD | -2.25% |
| 2022 Q4 | -0.80 CAD | -105.87% |
| 2022 Q2 | -1.92 CAD | -1029.41% |
| 2022 Q1 | -0.17 CAD | 93.15% |
| 2022 Q3 | 13.63 CAD | 809.9% |
| 2021 Q4 | -2.48 CAD | 47.46% |
| 2021 Q3 | -4.72 CAD | -1142.11% |
| 2021 Q1 | -0.06 CAD | 90.77% |
| 2021 Q2 | -0.38 CAD | -533.33% |
| 2021 FY | - CAD | 80.52% |
| 2020 Q1 | -0.92 CAD | 94.57% |
| 2020 Q2 | -1.74 CAD | -89.13% |
| 2020 Q3 | -0.85 CAD | 51.15% |
| 2020 Q4 | -0.65 CAD | 23.53% |
| 2020 FY | - CAD | 88.01% |
| 2019 FY | - CAD | 21.45% |
| 2019 Q4 | -16.93 CAD | -1126.81% |
| 2019 Q3 | -1.38 CAD | 90.27% |
| 2019 Q2 | -14.18 CAD | -9553.33% |
| 2019 Q1 | 0.15 CAD | 6621.74% |
| 2018 Q4 | -0.00 CAD | 99.88% |
| 2018 FY | - CAD | -23269.68% |
| 2018 Q3 | -1.89 CAD | 35.71% |
| 2018 Q2 | -2.94 CAD | -296.0% |
| 2018 Q1 | 1.50 CAD | 32.74% |
| 2017 FY | - CAD | 435.71% |
| 2017 Q4 | 1.13 CAD | 335.42% |
| 2017 Q3 | -0.48 CAD | -300.0% |
| 2017 Q2 | 0.24 CAD | 100.0% |
| 2017 Q1 | 0.12 CAD | 175.0% |
| 2016 Q1 | -0.37 CAD | 24.49% |
| 2016 Q2 | -0.12 CAD | 67.57% |
| 2016 Q3 | 0.01 CAD | 104.42% |
| 2016 Q4 | -0.16 CAD | -3118.87% |
| 2016 FY | - CAD | -5.66% |
| 2015 Q1 | -0.14 CAD | -104.84% |
| 2015 Q3 | 0.23 CAD | 304.22% |
| 2015 Q2 | 0.06 CAD | 140.64% |
| 2015 Q4 | -0.49 CAD | -313.04% |
| 2015 FY | - CAD | 64.19% |
| 2014 Q2 | -1.32 CAD | -780.0% |
| 2014 Q4 | 2.89 CAD | 3384.09% |
| 2014 Q3 | -0.09 CAD | 93.33% |
| 2014 Q1 | -0.15 CAD | -86.57% |
| 2014 FY | - CAD | -393.33% |
| 2013 FY | - CAD | -3.45% |
| 2013 Q2 | -0.02 CAD | 26.6% |
| 2013 Q3 | -0.07 CAD | -218.81% |
| 2013 Q4 | -0.08 CAD | -15.68% |
| 2013 Q1 | -0.03 CAD | 62.36% |
| 2012 Q1 | -0.11 CAD | 26.67% |
| 2012 Q3 | -0.05 CAD | -7.25% |
| 2012 FY | - CAD | -20.83% |
| 2012 Q2 | -0.05 CAD | 53.64% |
| 2012 Q4 | -0.08 CAD | -44.24% |
| 2011 Q1 | -0.03 CAD | 25.42% |
| 2011 Q4 | -0.15 CAD | -377.71% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | -0.03 CAD | 13.96% |
| 2011 Q3 | -0.03 CAD | -18.49% |
| 2010 Q4 | -0.04 CAD | 75.71% |
| 2010 Q1 | -0.03 CAD | 28.25% |
| 2010 Q2 | -0.01 CAD | 63.32% |
| 2010 FY | - CAD | -574.16% |
| 2010 Q3 | -0.17 CAD | -1689.47% |
| 2009 FY | - CAD | 70.33% |
| 2009 Q4 | -0.04 CAD | -64.09% |
| 2009 Q3 | -0.02 CAD | -161.9% |
| 2009 Q2 | -0.01 CAD | 43.62% |
| 2009 Q1 | -0.01 CAD | -1.36% |
| 2008 Q4 | -0.01 CAD | 40.49% |
| 2008 Q2 | -0.02 CAD | 70.66% |
| 2008 FY | - CAD | 36.84% |
| 2008 Q3 | -0.02 CAD | -32.8% |
| 2008 Q1 | -0.06 CAD | -239.04% |
| 2007 Q3 | -0.00 CAD | 97.56% |
| 2007 Q1 | 0.00 CAD | 0.0% |
| 2007 Q4 | -0.02 CAD | -379.49% |
| 2007 Q2 | -0.16 CAD | -26766.67% |
| 2007 FY | - CAD | -2535.9% |
| 2006 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Avicanna Inc. | -0.09 CAD | -1618.582% |
| Avant Brands Inc. | -0.61 CAD | -162.295% |
| Cardiol Therapeutics Inc. | -0.44 CAD | -263.636% |
| Crescita Therapeutics Inc. | -0.10 CAD | -1532.653% |
| Knight Therapeutics Inc. | -0.16 CAD | -900.0% |
| MediPharm Labs Corp. | -0.04 CAD | -4344.444% |
| OrganiGram Holdings Inc. | -2.82 CAD | 43.262% |
| Canopy Growth Corporation | -8.79 CAD | 81.797% |
| Willow Biosciences Inc. | -0.10 CAD | -1500.0% |
| Auxly Cannabis Group Inc. | -0.04 CAD | -3463.474% |